̳æâ³äîì÷èé ñåì³íàð «Ìîëåêóëÿðíà ìåäèöèíà»

                                                            2011 ð³ê

Íàçâà äîïîâ³ä³

Äîïîâ³äà÷

Äàòà ïðîâåäåííÿ

³òàì³í D ³ çäîðîâ’ÿ íàö³¿  ó ÕÕ² ñòîë³òò³.

êàíäèäàò á³îëîã³÷íèõ íàóê

Ë.². Àïóõîâñüêà

Ëàáîðàòîð³ÿ ìåäè÷íî¿ á³îõ³ì³¿ ²íñòèòóòó

²íñòèòóòó á³îõ³ì³¿ ³ì. Î.Â. Ïàëëàä³íà ÍÀÍ Óêðà¿íè

25 áåðåçíÿ 2011 p.

Ïàòîëîã³ÿ ã³ïîêàìïà ïðè õðîí³÷íîìó ñòðåñ³ : çíà÷åííÿ òà ìåõàí³çìè ðîçâèòêó

êàíäèäàò ìåäè÷íèõ íàóê

Â.Ì. Îðëîâñüêèé, í. ñï³âð. â³ää³ëó öèòîëî㳿. ²íñòèòóò ô³ç³îëî㳿 ³ì. Î.Î. Áîãîìîëüöÿ.

14 êâ³òíÿ 2011 p.

The O6-alkylguanine response:

Implications for glioma and melanoma therapy

Prof. Bernd Kaina,

Professor of Toxicology, Department of Toxicology, University of Mainz, Germany

 

29 êâ³òíÿ 2011 p.

Íåãåíîìí³ ìåõàí³çìè êàðä³î- ³ íåéðîïðoòåêòîðíîãî    

ñèãíàë³íãó çà íîðìè ³ ïàòîëî㳿

êàíäèäàò á³îëîã³÷íèõ íàóê À.Â. Êîöþðóáà

Ñòàðøèé íàóêîâèé ñï³âðîá³òíèê ²íñòèòóòó á³îõ³ì³¿ ³ì. Î.Â. Ïàëëàä³íà ÍÀÍ Óêðà¿íè

13 æîâòíÿ  2011 p.

Ñó¿öèäí³ àíòèãåíè,       àáî ³íäóêîâàíà äåíàòóðàö³ÿ ïðîòå¿í³â ó ôîðìóâàíí³ àëåðã³éíî¿ ðåàêö³¿

äîêòîð á³îëîã³÷íèõ íàóê  Ñ.Â. Âåðüîâêà

Çàâ³äóâà÷ ëàáîðàòî𳿠á³îõ³ì³¿ ²íñòèòóòó îòîëàðèíãîëî㳿 ³ì. Î.Ñ. Êîëîì³é÷åíêà ÀÌÍ Óêðà¿íè,

Ïðîâ³äíèé íàóêîâèé ñï³âðîá³òíèê ²íñòèòóòó á³îõ³ì³¿ ³ì. Î.Â. Ïàëëàä³íà ÍÀÍ Óêðà¿íè

24 ëèñòîïàäà 2011p.